Dicyclomine, an anticholinergic antispasmodic prescribed mainly for irritable bowel syndrome (IBS), carries a list of contraindications that goes well beyond the usual “tell your doctor if” boilerplate. Some people should never take it at all. Others can use it safely only with careful monitoring and dose adjustments. The drug works by blocking a type of nerve receptor found throughout the body, which is why its effects and risks extend far beyond the gut.
How Dicyclomine Works and Why That Matters for Safety
Dicyclomine relaxes smooth muscle in the intestinal wall, which is why it helps with the cramping and spasms of IBS. It does this by blocking muscarinic acetylcholine receptors, the same receptors that control a wide range of involuntary functions: digestion, heart rate, sweating, bladder contraction, saliva production, and certain brain processes. When you block those receptors in the gut, you get relief from spasms. When you block them elsewhere, you get side effects and, in the wrong patient, serious harm. Every contraindication on this drug’s label traces back to this basic mechanism: if a body system already has a problem, and that system depends on the same receptors dicyclomine blocks, the drug can make things worse.
Absolute Contraindications
Certain conditions make dicyclomine flatly off-limits. These are situations where the drug’s anticholinergic action would either worsen the underlying disease or create a dangerous complication.
- Obstructive GI disease: Dicyclomine slows gut motility. In someone with a bowel obstruction, pyloric stenosis, or another blockage, further slowing the gut can cause perforation or severe distension.
- Obstructive uropathy: The drug can reduce bladder muscle tone, making it harder to urinate. If the urinary tract is already partially blocked, dicyclomine can push the situation toward acute urinary retention.
- Severe ulcerative colitis: Anticholinergics can contribute to toxic megacolon in patients with severe inflammatory bowel disease, a rare but life-threatening complication.
- Myasthenia gravis: This autoimmune condition already impairs nerve-to-muscle signaling at acetylcholine receptors. Blocking those receptors further with dicyclomine can worsen muscle weakness, including the muscles used for breathing and swallowing.
- Narrow-angle glaucoma: Anticholinergics dilate the pupil and can increase intraocular pressure. In narrow-angle glaucoma, this effect can trigger an acute crisis that damages the optic nerve.
- Unstable cardiovascular status: In patients who are hemodynamically unstable, such as during acute hemorrhage, dicyclomine’s effects on heart rate and vascular tone can destabilize circulation further.
If you have been diagnosed with any of these conditions, the standard medical guidance is that dicyclomine should not be prescribed. These are not judgment calls that depend on dose or monitoring; they are hard stops.
Infants and Young Children
Dicyclomine is contraindicated in infants younger than six months. This is not a cautious suggestion; it reflects documented harm. Reports have linked even low doses of the drug in very young infants to respiratory distress and death.1Journal of Pharmacy Technology. Low Dose of Dicyclomine Associated with Respiratory Distress and Death in an Infant Infants have immature nervous systems and metabolize drugs differently than older children and adults, which makes them far more vulnerable to the respiratory depression that anticholinergics can cause.
For children between six months and two years, dicyclomine is generally not recommended either, though prescribing guidelines are slightly less absolute in that age range. The drug was once widely used for infant colic, but safety concerns led regulatory agencies to restrict its use in this population decades ago. If your child’s pediatrician is considering an antispasmodic for colic or GI symptoms, dicyclomine is unlikely to be the choice, and you should ask specifically about age-appropriate alternatives.
Heart Rhythm and Cardiovascular Cautions
Dicyclomine is not typically thought of as a cardiac drug, but its effects on the heart are real and clinically relevant. The drug exerts what is called a vagolytic effect: it reduces the braking action that the vagus nerve normally applies to the heart. The result is an increase in heart rate (sinus tachycardia) and faster electrical conduction through the heart’s internal wiring.
For most healthy people, a modest bump in heart rate from a therapeutic dose is not dangerous. But in patients with pre-existing conduction abnormalities, structural heart disease, or conditions affecting the autonomic nervous system, these effects can become problematic. A case report described the unmasking of Wolff-Parkinson-White syndrome, a conduction abnormality, after dicyclomine use. The drug’s vagolytic action increased conduction through an abnormal electrical pathway that had been clinically silent up to that point.2PubMed Central. Incidental Wolff-Parkinson-White Syndrome Discovered Following Dicyclomine Use: A Case Report
The practical concern is broader than one rare syndrome. If you have a history of arrhythmias, heart failure, coronary artery disease, or are taking other medications that affect heart rhythm, your prescriber needs to weigh dicyclomine’s cardiac effects against its GI benefits. The interaction potential with other drugs that speed up or alter heart conduction is a genuine consideration, especially since patients with IBS often take multiple medications.3PubMed Central. Incidental Wolff-Parkinson-White Syndrome Discovered Following Dicyclomine Use: A Case Report
Mental Health and Cognitive Effects
The same receptors dicyclomine blocks in the gut also exist in the brain, particularly a subtype called M1. This receptor plays a role in memory, attention, and perception. When dicyclomine crosses into the central nervous system and disrupts M1 signaling, the consequences can range from mild confusion and drowsiness to, in rare cases, frank psychosis with hallucinations and disorientation.4European Journal of Cardiovascular Medicine. A rare case series on anticholinergic drug induced psychosis
Anticholinergic-induced psychosis is not unique to dicyclomine; it can happen with many drugs in this class. But it catches people off guard because they associate dicyclomine with a stomach medication, not something that affects the brain. The risk is higher in older adults, people taking multiple anticholinergic drugs simultaneously, and anyone with pre-existing cognitive impairment or psychiatric conditions. If someone on dicyclomine develops sudden confusion, agitation, visual hallucinations, or bizarre behavior, the drug should be considered a possible cause and the prescriber contacted immediately.
Even at standard doses, some people experience milder cognitive effects like difficulty concentrating, memory lapses, or a feeling of mental “fog.” These tend to be dose-related and reversible, but they are worth flagging to your doctor rather than simply powering through.
Heat and Sweating
One of the less obvious risks of dicyclomine is its effect on the body’s ability to cool itself. Sweating is controlled in large part by the same muscarinic receptors the drug blocks. When those receptors are suppressed, sweat production drops. In a mild climate or an air-conditioned setting, you might not notice. But during exercise, in hot weather, or in any situation where your body needs to dissipate heat quickly, reduced sweating can lead to heat exhaustion or heat stroke.5PubMed. Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management
This risk applies to everyone taking the drug, but it is especially important for people who work outdoors, athletes, older adults whose thermoregulation is already less robust, and anyone living in a hot climate. The management strategy is straightforward: avoid prolonged heat exposure, stay hydrated, and cool the skin externally with water when needed.6PubMed. Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management If you notice that you have stopped sweating in situations where you normally would, that is a sign to take the thermoregulatory risk seriously and discuss it with your prescriber.
Older Adults and Anticholinergic Burden
Geriatric patients face a compounded version of nearly every risk described above. Age-related changes in kidney and liver function mean the drug clears more slowly, so standard adult doses can produce stronger and longer-lasting effects. Older brains are more sensitive to anticholinergic effects on cognition, and many seniors are already taking other medications with anticholinergic properties: certain antihistamines, bladder medications, antidepressants, and antipsychotics. Each additional anticholinergic drug stacks the risk of confusion, falls, urinary retention, and constipation.
The American Geriatrics Society’s Beers Criteria, a widely used reference for potentially inappropriate medications in older adults, flags anticholinergics like dicyclomine as drugs to avoid in geriatric patients when possible. This does not mean the drug is absolutely prohibited in every older person, but it does mean prescribers are expected to try alternatives first and, if dicyclomine is used, to start at the lowest effective dose with close monitoring. If you are over 65 and have been prescribed dicyclomine, it is reasonable to ask your doctor whether a non-anticholinergic option for your IBS symptoms might work just as well.
Pregnancy and Breastfeeding
Dicyclomine’s safety profile during pregnancy is not well established, which in practice means it is generally avoided unless the benefit clearly outweighs the uncertainty. Animal studies have not shown clear-cut harm at therapeutic doses, but the lack of robust human data keeps most prescribers cautious. If you are pregnant and dealing with IBS symptoms, your provider will typically reach for dietary changes, fiber supplementation, or other medications with a more established pregnancy safety record before considering dicyclomine.
During breastfeeding, the concern is more direct. Dicyclomine is known to pass into breast milk, and given the documented risks of respiratory distress in very young infants, nursing mothers are advised against using the drug. The FDA labeling lists breastfeeding as a contraindication. If you are breastfeeding and need antispasmodic treatment, your doctor should choose an alternative that is considered compatible with lactation.
Abuse Potential and Overdose
Dicyclomine is not a controlled substance, and it is rarely discussed in the context of drug abuse. But case reports exist. One documented case involved an 18-year-old who abused dicyclomine for a year and a half, developing overt anticholinergic toxicity as a result.7PubMed Central. A rare case of dicyclomine abuse The appeal, in the rare instances where abuse occurs, likely relates to the drug’s central nervous system effects: at supratherapeutic doses, anticholinergics can produce euphoria, altered perception, and a dissociative state. These effects come with a steep price, including dangerous tachycardia, hyperthermia, urinary retention, seizures, and delirium.
Overdose with dicyclomine, whether intentional or accidental, produces a recognizable pattern sometimes described in shorthand as “hot as a hare, blind as a bat, dry as a bone, red as a beet, mad as a hatter.” The skin becomes hot and flushed, the mouth dries out, the pupils dilate and blur vision, the heart races, and confusion or agitation sets in. In severe cases, this can progress to seizures, coma, and respiratory failure. Treatment is supportive, and in severe toxicity, a specific antidote called physostigmine may be used under medical supervision. If you suspect someone has taken too much dicyclomine, it is a medical emergency.
Drug Interactions That Change the Risk Profile
Because dicyclomine blocks muscarinic receptors throughout the body, combining it with other drugs that have anticholinergic effects produces an additive burden. Common offenders include first-generation antihistamines like diphenhydramine, tricyclic antidepressants like amitriptyline, older antipsychotics, and overactive bladder medications like oxybutynin. When two or more of these are taken together, the side effects of each individual drug amplify: dry mouth becomes severe, mild drowsiness becomes pronounced sedation, and the risk of urinary retention, constipation, and confusion increases sharply.
Dicyclomine can also slow gastric emptying, which means it may affect how quickly other oral medications are absorbed. For drugs with a narrow therapeutic window, where the difference between an effective dose and a toxic dose is small, this can matter. If you are starting dicyclomine and are already on medications for seizures, blood thinning, or heart rhythm, your prescriber should review potential absorption interactions.
Alcohol deserves a specific mention. Both alcohol and dicyclomine cause drowsiness and impair coordination. Together, they can produce dangerous levels of sedation. This is not a theoretical concern: many IBS patients are young, active adults who may not think twice about having a drink while on a “stomach pill.” The combination is worth flagging clearly at the time of prescribing.
When Common Side Effects Signal a Deeper Problem
Dry mouth, blurred vision, mild constipation, and occasional dizziness are expected anticholinergic side effects of dicyclomine. Most people tolerate them at standard doses, and they often improve after the first week or two. The question is when a side effect crosses from nuisance into warning sign.
Urinary retention that progresses beyond mild hesitancy, especially in men with enlarged prostates, can become an emergency if the bladder cannot empty at all. Constipation that becomes severe or is accompanied by abdominal distension could indicate ileus, a shutdown of bowel motility. Heart palpitations, especially if they feel irregular rather than just fast, warrant an evaluation given the drug’s effects on cardiac conduction. And any sudden change in mental status, from confusion to hallucinations, should be treated as a possible anticholinergic toxicity event rather than dismissed as a quirky reaction.
The general principle is that dicyclomine’s side effects exist on a spectrum. At one end, they are annoying but manageable. At the other end, they shade into the same territory as its contraindications. Recognizing when you have crossed from one zone to the other, and contacting your prescriber when you do, is the most practical safety measure for anyone taking this drug.